comparemela.com

Brokerages forecast that Brickell Biotech, Inc. (NASDAQ:BBI – Get Rating) will post earnings per share of ($0.08) for the current quarter, according to Zacks. Three analysts have issued estimates for Brickell Biotech’s earnings. The highest EPS estimate is ($0.05) and the lowest is ($0.12). Brickell Biotech posted earnings per share of ($0.15) during the same […]

Related Keywords

United States ,William Blair ,Morgan Stanley ,Brickell Biotech Inc ,Geode Capital Management ,Zacks Investment Research ,Blackrock Inc ,Nasdaq ,Brickell Biotech Company Profile Get Rating ,Brickell Biotech ,Get Rating ,Capital Management ,Street Corp ,Two Sigma Investments ,Sigma Investments ,Xbiotech Company Profile ,Nasdaq Bbi ,Bbi ,Medical ,Ratings ,Consensus ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.